Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
This trial will evaluate the efficacy and safety of paclitaxel, carboplatin and bevacizumab
combination, administered biweekly, in patients with pretreated, advanced non small cell lung
cancer.